The new five-year plan calls for more original scientific research to facilitate the country's bid for self-reliance.

Simon & Schuster has named a former Amazon.com executive as its new CEO. The publisher announced Monday that Greg Greeley’s ...

Learn more about whether Revvity, Inc. or 10x Genomics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

They've devised a multi-pronged approach using three advanced scientific strategies: breeding, biotechnology, and biocontrol. Experts change how they will reintroduce endangered trees first appeared ...

The family of Henrietta Lacks has reached an undisclosed settlement with pharmaceutical company Novartis, marking another legal victory in their effort to hold companies accountable for profiting from ...

Dianthus Therapeutics, Inc. (Nasdaq: DNTH) (“Dianthus” or the “Company”), a clinical-stage biotechnology company dedicated to developing next-generation therapies to transform the treatment of severe ...

Dianthus intends to use the net proceeds from this offering to advance the Company’s clinical and preclinical development activities, commercial readiness activities as well as for working capital and ...

The Russian government has funded anti-ageing technology, investing heavily in cellular rejuvenation and immune system ...

US president Donald Trump and Secretary of State Marco Rubio are seeking regime change in Cuba by the end of 2026. Their actions expose the hypocrisy of US policy toward Cuba over decades — claiming ...

Almost every morning, Muhammad Jalal finds himself squeezed between shelves and equipment in a laboratory at Anhui Agricultural ...

San Francisco-based biotechnology company Codexis has reported strong fourth-quarter and fiscal year 2025 financial results, with the company's focus on RNA medicine gaining significant momentum. In a ...